References
- Bevan RJ, Harrison P. 2017. Threshold and non-threshold chemical carcinogens: a survey of the present regulatory landscape. Regul Toxicol Pharmacol. 88:291–302.
- Billington R, Lewis RW, Mehta JM, Dewhurst I. 2010. The mouse carcinogenicity study is no longer a scientifically justifiable core data requirement for the safety assessment of pesticides. Crit Rev Toxicol. 40(1):35–49.
- Boorman GA, Maronpot RR, Eustis SL. 1994. Rodent carcinogenicity bioassay: past, present, and future. Toxicol Pathol. 22(2):105–111.
- Corvi R, Madia F, Guyton KZ, Kasper P, Rudel R, Colacci A, Kleinjans J, Jennings P. 2017. Moving forward in carcinogenicity assessment: report of an EURL ECVAM/ESTIV workshop. Toxicol In Vitro. 45 (Pt 3):278–286.
- Corvi R, Madia F. 2018. EURL ECVAM Genotoxicity and Carcinogenicity Consolidated Database of Ames Positive Chemicals [Internet]. Sevilla (Spain): European Commission, Joint Research Centre (JRC) [accessed Dec 2019]. http://data.europa.eu/89h/jrc-eurl-ecvam-genotoxicity-carcinogenicity-ames.
- Doe JE, Boobis AR, Dellarco V, Fenner-Crisp PA, Moretto A, Pastoor TP, Schoeny RS, Seed JG, Wolf DC. 2019. Chemical carcinogenicity revisited 2: current knowledge of carcinogenesis shows that categorization as a carcinogen or non-carcinogen is not scientifically credible. Regul Toxicol Pharmacol. 103:124–129.
- Dunnick JK, Forbes PD, Eustis SL, Hardisty JF, Goodman DG. 1991. Tumors of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiation. Toxicol Sci. 16(1):92–102.
- EFSA (European Food Safety Authority). 2011. Scientific opinion on genotoxicity testing strategies applicable to food and feed safety assessment [Internet]. Parma (Italy): European Food Safety Authority; [accessed Dec 2019]. https://www.efsa.europa.eu/en/efsajournal/pub/2379.
- Forbes PD, Urbach F. 1975a. Experimental modification of photocarcinogenesis. II. Fluorescent whitening agents and simulated solar UVR. Food Cosmet Toxicol. 13(3):339–342.
- Forbes PD, Urbach F. 1975b. Experimental modification of photocarcinogenesis. III. Simulation of exposure to sunlight and fluorescent whitening agents. Food Cosmet Toxicol. 13(3):343–345.
- Fung VA, Barrett JC, Huff J. 1995. The carcinogenesis bioassay in perspective: application in identifying human cancer hazards. Environ Health Perspect. 103(7–8):680–683.
- Gold LS, Slone TH, Ames BN. 1998. What do animal cancer tests tell us about human cancer risk?: overview of analyses of the carcinogenic potency database. Drug Metab Rev. 30(2):359–404.
- Goodman JI. 2018. Goodbye to the bioassay. Toxicol Res. 7(4):558–564.
- Gordis L. 2014. Assessing the validity and reliability of diagnostic and screening test (Chapter 5). In: Gordis L, editor. Epidemiology. 5th ed. Philadelphia: Elsevier Saunders; p. 88–115.
- Gottmann E, Kramer S, Pfahringer B, Helma C. 2001. Data quality in predictive toxicology: reproducibility of rodent carcinogenicity experiments. Environ Health Perspect. 109(5):509–514.
- Haseman JK. 1983. A reexamination of false-positive rates for carcinogenesis studies. Fundam Appl Toxicol. 3(4):334–339.
- Haseman JK, Huff JE, Zeiger E, McConnell EE. 1987. Comparative results of 327 chemical carcinogenicity studies. Environ Health Perspect. 74:229–235.
- IARC (International Agency for Research on Cancer). 1975. Some Aziridines, N-, S‐ and O-Mustards and Selenium: Melphalan, Medphalan & Merphalan. IARC monograph vol. 9 [Internet]. Lyon: International Agency for Research on Cancer/World Health Organization; [accessed Dec 2019]. https://monographs.iarc.fr/monographs-available/.
- IARC (International Agency for Research on Cancer). 2012. Pharmaceuticals: Methoxsalen plus Ultraviolet A Radiation. IARC monograph vol. 100A [Internet]. Lyon: International Agency for Research on Cancer/World Health Organization; [accessed Dec 2019]. https://monographs.iarc.fr/monographs-available/.
- IARC (International Agency for Research on Cancer). 2018. DDT, Lindane, and 2,4-D: Lindane. IARC monograph vol. 113 [Internet]. Lyon: International Agency for Research on Cancer/World Health Organization; [accessed Dec 2019]. https://monographs.iarc.fr/monographs-available/.
- IARC (International Agency for Research on Cancer). 2019. Preamble to the IARC Monographs (Amended January 2019) [Internet]. Lyon: International Agency for Research on Cancer/World Health Organization; [accessed Dec 2019]. https://monographs.iarc.fr/iarc-monographs-preamble-preamble-to-the-iarc-monographs/.
- ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use). 1995. Need for carcinogenicity studies of pharmaceuticals S1A [Internet]. Geneva: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use; [accessed Dec 2019]. https://www.ich.org/page/safety-guidelines.
- ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use). 1997. Testing for carcinogenicity of pharmaceuticals, safety guideline S1B [Internet]. Geneva: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use; [accessed Dec 2019]. https://www.ich.org/page/safety-guidelines.
- ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use). 2016. Proposed change to rodent carcinogenicity testing of pharmaceuticals – regulatory notice document [Internet]. Geneva: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use; [accessed Dec 2019]. https://www.ich.org/page/safety-guidelines.
- JMPR (Joint FAO/WHO Meeting on Pesticide Residues). 1999. WHO Evaluations Part II: Toxicology. Permethrin [Internet]. Rome: Joint FAO/WHO Meeting on Pesticide Residues; [accessed Jan 2020]. https://www.who.int/foodsafety/publications/jmpr-monographs/en/.
- Kirkland D, Reeve L, Gatehouse D, Vanparys P. 2011. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Mutat Res. 721(1):27–73.
- Knight A, Bailey J, Balcombe J. 2006. Animal carcinogenicity studies: 1. Poor human predictivity. Altern Lab Anim. 34(1):19–27.
- Kodell RL. 2012. Should we assess tumorigenicity with the Peto or Poly-k Test? Stat Biopharm Res. 4(2):118–124.
- Lave LB, Ennever FK, Rosenkranz HS, Omenn GS. 1988. Information value of the rodent bioassay. Nature. 336(6200):631–633.
- McConnell EE. 1995. Historical review of the rodent bioassay and future directions. Regul Toxicol Pharmacol. 21(1):38–43.
- McConnell EE, Solleveld HA, Swenberg JA, Boorman GA. 1986. Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. J Natl Cancer Inst. 76(2):283–289.
- Meek ME, Bucher JR, Cohen SM, Dellarco V, Hill RN, Lehman-McKeeman LD, Longfellow DG, Pastoor T, Seed J, Patton DE, et al. 2003. A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol. 33(6):591–653.
- Miller DC, Dunn RL, Wei JT. 2006. Assessing the performance and validity of diagnostic tests and screening programs. In: Penson DF, Wei JT, editors. Clinical research methods for surgeons. Totowa (U.S.): Humana Press; p. 157–173.
- Nohmi T. 2018. Thresholds of genotoxic and non-genotoxic carcinogens. Toxicol Res. 34(4):281–290.
- OECD (Organisation for Economic Co-operation and Development). 2012. Series on Testing and Assessment, Guidance Document No. 116: Guidance on the Conduct and Design of Chronic Toxicity and Carcinogenicity Studies [Internet]. Paris: Organisation for Economic Co-operation and Development, [accessed Dec 2019]. http://www.oecd.org/chemicalsafety/testing/series-testing-assessment-publications-number.htm.
- OECD (Organisation for Economic Co-operation and Development). 2018. Test No. 451: Carcinogenicity Studies [Internet]. Paris: Organisation for Economic Co-operation and Development, [accessed Dec 2019]. https://www.oecd-ilibrary.org/environment/test-no-451-carcinogenicity-studies_9789264071186-en.
- Osimitz TG, Droege W, Boobis AR, Lake BG. 2013. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans. Food Chem Toxicol. 60:550–562.
- Podger DM. 1983. Mutagenicity of 5-azacytidine in Salmonella typhimurium. Mutat Res. 121(1):1–6.
- Pugsley MK, Towart R, Authier S, Gallacher DJ, Curtis MJ. 2011. Innovation in safety pharmacology testing. J Pharmacol Toxicol Methods. 64(1):1–6.
- Reddy MV, Sistare FD, Christensen JS, Deluca JG, Wollenberg GK, Degeorge JJ. 2010. An evaluation of chronic 6- and 12-month rat toxicology studies as predictors of 2-year tumor outcome. Vet Pathol. 47(4):614–629.
- Sistare FD, Morton D, Alden C, Christensen J, Keller D, Jonghe SD, Storer RD, Reddy MV, Kraynak A, Trela B, et al. 2011. An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelines. Toxicol Pathol. 39(4):716–744.
- Smith CC, Archer GE, Forster EJ, Lambert TR, Rees RW, Lynch AM. 1999. Analysis of gene mutations and clastogenicity following short-term treatment with azathioprine in MutaTMMouse. Environ Mol Mutagen. 34(2–3):131–139.
- Smith MT, Guyton KZ, Gibbons CF, Fritz JM, Portier CJ, Rusyn I, DeMarini DM, Caldwell JC, Kavlock RJ, Lambert PF, et al. 2016. Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis. Environ Health Perspect. 124(6):713–721.
- Suarez-Torres JD, Ciangherotti CE, Jimenez-Orozco FA. 2020. Insights into toxicology, safety pharmacology, and drug dependence testing: the performance and predictive values of nonclinical tests. J Pharmacol Toxicol Methods [Internet]. 103:106684.
- Tomatis L, Aitio A, Wilbourn J, Shuker L. 1989. Human carcinogens so far identified. Jpn J Cancer Res. 80(9):795–807.
- U.K. COM (U.K. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment). 2011. A strategy for testing of chemicals for genotoxicity [Internet]. Petty France (U.K): U.K. Food Standards Agency; [accessed Dec 2019]. https://www.gov.uk/government/publications/a-strategy-for-testing-of-chemicals-for-genotoxicity.
- U.S. CDC (Centers for Disease Control and Prevention). 2012. Principles of Epidemiology in Public Health Practice, Third Edition. An Introduction to Applied Epidemiology and Biostatistics. Lesson 1: Introduction to Epidemiology, Section 1: Definition of Epidemiology [Internet]. Atlanta: U.S. Centers for Disease Control and Prevention; [accessed Dec 2019]. https://www.cdc.gov/csels/dsepd/ss1978/lesson1/section1.html.
- U.S. EPA (Environmental Protection Agency). 1998. Health Effects Test Guidelines: 870.4200 – Carcinogenicity [Internet]. Washington, DC: United States Environmental Protection Agency; [accessed Dec 2019]. https://www.epa.gov/test-guidelines-pesticides-and-toxic-substances/series-870-health-effects-test-guidelines.
- U.S. EPA (Environmental Protection Agency). 2005. Guidelines for Carcinogen Risk Assessment [Internet]. Washington, DC: United States Environmental Protection Agency; [accessed Dec 2019]. https://www.epa.gov/risk/guidelines-carcinogen-risk-assessment.
- U.S. FDA (Food and Drug Administration). 2002. Guidance for Industry: Preparation of Food Contact Notifications for Food Contact Substances (Toxicology Recommendations) [Internet]. Silver Spring: Food and Drug Administration (U.S.); [accessed Dec 2019]. https://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ucm081825.htm.
- U.S. FDA (Food and Drug Administration). 2005. Guidance for Industry Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients [Internet]. Silver Spring: Food and Drug Administration (U.S.); [accessed Dec 2019]. https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm079250.pdf.
- U.S. FDA (Food and Drug Administration). 2006a. Redbook 2000: IV.C.6 Carcinogenicity Studies with Rodents [Internet]. Silver Spring: U.S. FDA Center for Food Safety and Applied Nutrition; [accessed Dec 2019]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/redbook-2000-ivc6-carcinogenicity-studies-rodents.
- U.S. FDA (Food and Drug Administration). 2006b. Guidance for Industry: Summary Table of Recommended Toxicological Testing for Additives Used in Food [Internet]. Silver Spring: Food and Drug Administration (U.S.); [accessed Dec 2019]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-summary-table-recommended-toxicological-testing-additives-used-food.
- U.S. FDA (Food and Drug Administration). 2006c. Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Carcinogenicity Testing VICH GL28 [Internet]. Silver Spring: Food and Drug Administration (U.S.); [accessed Dec 2019]. https://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/ucm052527.pdf.
- U.S. FDA (Food and Drug Administration). 2007. Redbook 2000: IV.C.8. In-Utero Exposure Phase for Addition to Carcinogenicity Studies or Chronic Toxicity Studies with Rodents [Internet]. Silver Spring: Food and Drug Administration (U.S.); [accessed Nov 2019]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/redbook-2000-ivc8-utero-exposure-phase-addition-carcinogenicity-studies-or-chronic-toxicity-studies.
- U.S. NTP (National Toxicology Program). 2016a. Report on Carcinogens Table of Contents: Introduction [Internet]. Research Triangle Park: U.S. National Institute of Environmental Health Sciences; [accessed Dec 2019]. https://ntp.niehs.nih.gov/pubhealth/roc/index-1.html.
- U.S. NTP (National Toxicology Program). 2005. Toxicology and Carcinogenesis Studies of Malachite Green Chloride and Leucomalachite Green in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Technical Report Series. Technical Report No. 527; PMID: 15891780
- U.S. NTP (National Toxicology Program). 2016b. Toxicology and Carcinogenesis Studies of Trim® VX (CASRN TRIMVX) in Wistar Han Rats and B6C3F1 Mice (Inhalation Studies). National Toxicology Program Technical Report Series. Technical Report No. 591; [ accessed Dec 2019]. https://ntp.niehs.nih.gov/whatwestudy/testpgm/cartox/index.html.
- Valentin J-P, Bialecki R, Ewart L, Hammond T, Leishmann D, Lindgren S, Martinez V, Pollard C, Redfern W, Wallis R, et al. 2009. A framework to assess the translation of safety pharmacology data to humans. J Pharmacol Toxicol Methods. 60(2):152–158.
- van der Laan JW, Buitenhuis WHW, Wagenaar L, Soffers AEMF, van Someren EP, Krul CAM, Woutersen RA. 2016. Prediction of the carcinogenic potential of human pharmaceuticals using repeated dose toxicity data and their pharmacological properties. Front Med. 3:45.
- Van Oosterhout JPJ, Van Der Laan JW, De Waal EJ, Olejniczak K, Hilgenfeld M, Schmidt V, Bass R. 1997. The utility of two rodent species in carcinogenic risk assessment of pharmaceuticals in Europe. Regul Toxicol Pharmacol. 25(1):6–17.
- WHO (World Health Organization). 1990. Environmental Health Criteria 94: Permethrin [Internet]. Geneva: World Health Organization; [accessed Jan 2020]. http://www.inchem.org/documents/ehc/ehc/ehc94.htm#SectionNumber:7.6.
- Williams DE. 2012. The rainbow trout liver cancer model: response to environmental chemicals and studies on promotion and chemoprevention. Comp Biochem Physiol. Toxicol Pharmacol. 155(1):121–127.
- Williams DE, Orner G, Willard KD, Tilton S, Hendricks JD, Pereira C, Benninghoff AD, Bailey GS. 2009. Rainbow trout (Oncorhynchus mykiss) and ultra-low dose cancer studies. Comp Biochem Physiol Toxicol Pharmacol. 149(2):175–181.
- Zimmermann FK, Scheel I. 1984. Genetic effects of 5-azacytidine in Saccharomyces cerevisiae. Mutat Res Lett. 139(1):21–24.